Art

J-GLOBAL ID：201902261158520946   Reference number：19A2738042

Serum Anti-Apo B Antibody Level as Residual CVD Marker in DM Patients under Statin Treatment

スタチン治療下のDM患者における残留CVDマーカーとしての血清抗アポB抗体レベル

Author (9)： Yamamoto Hiroyasu (Department of Biomedical Informatics, Division of Health Sciences, Osaka University Graduate School of Medicine) ,  Kawamura Mari (Department of Biomedical Informatics, Division of Health Sciences, Osaka University Graduate School of Medicine) ,  Kochi Ikoi (Department of Biomedical Informatics, Division of Health Sciences, Osaka University Graduate School of Medicine) ,  Imai Minami (Department of Biomedical Informatics, Division of Health Sciences, Osaka University Graduate School of Medicine) ,  Murata Yukie (Department of Biomedical Informatics, Division of Health Sciences, Osaka University Graduate School of Medicine) ,  Suzuki Toshinobu (Department of Endocrinology and Diabetes in NTT West Osaka Hospital) ,  Chen Yingchao (Department of Endocrinology and Diabetes in NTT West Osaka Hospital) ,  Hashimoto Kunihiko (Department of Endocrinology and Diabetes in NTT West Osaka Hospital) ,  Kihara Shinji (Department of Biomedical Informatics, Division of Health Sciences, Osaka University Graduate School of Medicine)
Material： Journal of Atherosclerosis and Thrombosis (Web)  (J Atheroscler Thromb (Web))
Volume： 26  Issue： 10  Page： 931-943(J-STAGE)  Publication year： 2019 
JST Material Number： U0153A  ISSN： 1880-3873  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： human ,...
Semi thesaurus term： Diabetic microangiopathy ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=19A2738042&from=J-GLOBAL&jstjournalNo=U0153A") }}

Author keywords (4)： Apolipoprotein B-100 ,  Autoantibody ,  Cardiovascular disease ,  Diabetes

JST classification (1)： Metabolic diseases,nutritional diseases in general.  (GD05010J)

Reference (55)：

• 1) WHO: Global report on diabetes. 2016
• 2) Naslafkih A and Sestier F: Diabetes mellitus related morbidity, risk of hospitalization and disability. J Insur Med, 2003; 35: 102-113
• 3) Cholesterol Treatment Trialists C, Baigent C, Blackwell L, Emberson J, Holland LE, Reith C, Bhala N, Peto R, Barnes EH, Keech A, Simes J and Collins R: Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet, 2010; 376: 1670-1681
• 4) Ross R: Atherosclerosis--an inflammatory disease. N Engl J Med, 1999; 340: 115-126
• 5) Koltsova EK, Hedrick CC and Ley K: Myeloid cells in atherosclerosis: a delicate balance of anti-inflammatory and proinflammatory mechanisms. Curr Opin Lipidol, 2013; 24: 371-380

Terms in the title (9)： スタチン ,  治療 ,  患者 ,  残留 ,  CVD ,  マーカー ,  血清 ,  アポB ,  抗体